Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Obstet Gynaecol Res. 2011 Dec 5;38(1):77–83. doi: 10.1111/j.1447-0756.2011.01697.x

Figure 2. BV is recalcitrant to systemic metronidazole therapy among HSV-2 seropositive women.

Figure 2

Longitudinal results from representative HSV-2 seropositive study participants diagnosed with asymptomatic BV at enrollment. Red continuous horizontal line: BV (Nugent score ≥ 7); blue discontinuous horizontal line: abnormal vaginal flora (Nugent score ≥ 4). Explanation of figure legend: (○) RBC, vaginal red blood cells; (⊕) WBC, vaginal white blood cells; (✳) HSV-2, genital tract detection of HSV-2 DNA; and (⇓) Treatment, initiation of 7 day course of oral metronidazole therapy.